ATP13A2 抗体 (AA 1001-1080)
-
- 抗原 See all ATP13A2 抗体
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
-
抗原表位
- AA 1001-1080
-
适用
- 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This ATP13A2 antibody is un-conjugated
-
应用范围
- ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
- 交叉反应
- 大鼠
- 预测反应
- Human,Mouse,Cow,Pig,Horse,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human ATP13A2
- 亚型
- IgG
- Top Product
- Discover our top product ATP13A2 Primary Antibody
-
anti-ATPase Type 13A2 (ATP13A2) (AA 200-300) antibody
ATP13A2 适用: 人, 小鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 68-154) antibodyATP13A2 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 4B7 unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 582-736) antibodyATP13A2 适用: 人 ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 68-154) antibodyATP13A2 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 195-209) antibodyATP13A2 适用: 人, 大鼠 IHC 宿主: 兔 Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 147-161) antibodyATP13A2 适用: 小鼠 IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 67-210) antibodyATP13A2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
- 抗原
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
- 别名
- PARK9/ATP13A2 (ATP13A2 产品)
- 别名
- ATP13A2 antibody, 1110012E06Rik antibody, AA589443 antibody, RGD1307977 antibody, im:7147302 antibody, zgc:136762 antibody, CLN12 antibody, HSA9947 antibody, KRPPD antibody, PARK9 antibody, ATPase 13A2 antibody, ATPase type 13A2 antibody, probable cation-transporting ATPase 13A2 antibody, ATP13A2 antibody, Atp13a2 antibody, atp13a2 antibody, PTRG_01071 antibody, MCYG_01937 antibody, LOC100439053 antibody
- 背景
-
Synonyms: AT132_HUMAN, Atp13a2, ATPase type 13A2, CLN12, HSA9947, KRPPD, PARK9, Probable cation transporting ATPase 13A2, Probable cation-transporting ATPase 13A2, Putative ATPase, RP1-37C10.4.
Background: ATP13A2 is a 1,180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations. Expressed as multiple alternative spliced isoforms, ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, thereby participating in the active transport of ions across cellular membranes. Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), a rare hereditary type of Parkinson?s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia. The ATP13A2 gene maps to human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8 % of the human genome.
- 途径
- Ribonucleoside Biosynthetic Process
-
